These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 28602974)
1. FZD8, a target of p53, promotes bone metastasis in prostate cancer by activating canonical Wnt/β-catenin signaling. Li Q; Ye L; Zhang X; Wang M; Lin C; Huang S; Guo W; Lai Y; Du H; Li J; Song L; Peng X Cancer Lett; 2017 Aug; 402():166-176. PubMed ID: 28602974 [TBL] [Abstract][Full Text] [Related]
2. Wnt receptor Frizzled 8 is a target of ERG in prostate cancer. Chakravarthi BVSK; Chandrashekar DS; Hodigere Balasubramanya SA; Robinson AD; Carskadon S; Rao U; Gordetsky J; Manne U; Netto GJ; Sudarshan S; Palanisamy N; Varambally S Prostate; 2018 Dec; 78(16):1311-1320. PubMed ID: 30051493 [TBL] [Abstract][Full Text] [Related]
3. LRP5 knockdown: effect on prostate cancer invasion growth and skeletal metastasis in vitro and in vivo. Rabbani SA; Arakelian A; Farookhi R Cancer Med; 2013 Oct; 2(5):625-35. PubMed ID: 24403228 [TBL] [Abstract][Full Text] [Related]
4. Frizzled-8 integrates Wnt-11 and transforming growth factor-β signaling in prostate cancer. Murillo-Garzón V; Gorroño-Etxebarria I; Åkerfelt M; Puustinen MC; Sistonen L; Nees M; Carton J; Waxman J; Kypta RM Nat Commun; 2018 May; 9(1):1747. PubMed ID: 29717114 [TBL] [Abstract][Full Text] [Related]
5. PHF21B overexpression promotes cancer stem cell-like traits in prostate cancer cells by activating the Wnt/β-catenin signaling pathway. Li Q; Ye L; Guo W; Wang M; Huang S; Peng X J Exp Clin Cancer Res; 2017 Jun; 36(1):85. PubMed ID: 28645312 [TBL] [Abstract][Full Text] [Related]
6. m Lang C; Yin C; Lin K; Li Y; Yang Q; Wu Z; Du H; Ren D; Dai Y; Peng X Clin Transl Med; 2021 Jun; 11(6):e426. PubMed ID: 34185427 [TBL] [Abstract][Full Text] [Related]
7. Transcriptional downregulation of miR-133b by REST promotes prostate cancer metastasis to bone via activating TGF-β signaling. Huang S; Wa Q; Pan J; Peng X; Ren D; Li Q; Dai Y; Yang Q; Huang Y; Zhang X; Zhou W; Yuan D; Cao J; Li Y; He P; Tang Y Cell Death Dis; 2018 Jul; 9(7):779. PubMed ID: 30006541 [TBL] [Abstract][Full Text] [Related]
8. FZD8 Indicates a Poor Prognosis and Promotes Gastric Cancer Invasion and Metastasis via B-Catenin Signaling Pathway. Chen W; Liu Z; Mai W; Xiao Y; You X; Qin L Ann Clin Lab Sci; 2020 Jan; 50(1):13-23. PubMed ID: 32161008 [TBL] [Abstract][Full Text] [Related]
9. MAZ promotes prostate cancer bone metastasis through transcriptionally activating the KRas-dependent RalGEFs pathway. Yang Q; Lang C; Wu Z; Dai Y; He S; Guo W; Huang S; Du H; Ren D; Peng X J Exp Clin Cancer Res; 2019 Sep; 38(1):391. PubMed ID: 31488180 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer. Huang S; Wa Q; Pan J; Peng X; Ren D; Huang Y; Chen X; Tang Y J Exp Clin Cancer Res; 2017 Dec; 36(1):173. PubMed ID: 29202848 [TBL] [Abstract][Full Text] [Related]
11. Modulation of beta-catenin-mediated TCF-signalling in prostate cancer cell lines by wild-type and mutant p53. Prowald A; Cronauer MV; von Klot C; Eilers T; Rinnab L; Herrmann T; Spindler KD; Montenarh M; Jonas U; Burchardt M Prostate; 2007 Dec; 67(16):1751-60. PubMed ID: 17929268 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of miR‑19a‑3p promotes invasion, migration and bone metastasis via activating TGF‑β signaling in prostate cancer. Wa Q; Li L; Lin H; Peng X; Ren D; Huang Y; He P; Huang S Oncol Rep; 2018 Jan; 39(1):81-90. PubMed ID: 29138858 [TBL] [Abstract][Full Text] [Related]
13. Cancer-derived exosomal miR-375 targets DIP2C and promotes osteoblastic metastasis and prostate cancer progression by regulating the Wnt signaling pathway. Liu Y; Yang C; Chen S; Liu W; Liang J; He S; Hui J Cancer Gene Ther; 2023 Mar; 30(3):437-449. PubMed ID: 36434177 [TBL] [Abstract][Full Text] [Related]
14. ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-β-catenin signaling. Pai VC; Hsu CC; Chan TS; Liao WY; Chuu CP; Chen WY; Li CR; Lin CY; Huang SP; Chen LT; Tsai KK Oncogene; 2019 Feb; 38(8):1340-1353. PubMed ID: 30266990 [TBL] [Abstract][Full Text] [Related]
15. CAPE suppresses migration and invasion of prostate cancer cells via activation of non-canonical Wnt signaling. Tseng JC; Lin CY; Su LC; Fu HH; Yang SD; Chuu CP Oncotarget; 2016 Jun; 7(25):38010-38024. PubMed ID: 27191743 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway. Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/β-catenin signaling. Guan H; Liu C; Fang F; Huang Y; Tao T; Ling Z; You Z; Han X; Chen S; Xu B; Chen M Oncotarget; 2017 Feb; 8(9):14693-14707. PubMed ID: 28107193 [TBL] [Abstract][Full Text] [Related]
18. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway. Wu G; Liu A; Zhu J; Lei F; Wu S; Zhang X; Ye L; Cao L; He S Oncotarget; 2015 Oct; 6(30):28882-94. PubMed ID: 26337084 [TBL] [Abstract][Full Text] [Related]
19. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis. Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887 [TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA SNHG12 promotes cell proliferation and activates Wnt/β-catenin signaling in prostate cancer through sponging microRNA-195. Song J; Wu X; Ma R; Miao L; Xiong L; Zhao W J Cell Biochem; 2019 Aug; 120(8):13066-13075. PubMed ID: 30945357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]